Back

Risks of cardiac implantable electronic device procedures performed with uninterrupted direct oral anticoagulant therapy

26 August 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 2 - ICD Automatic implantable cardioverter / defibrillator ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Alexandra Pouliot

Maisonneuve Rosemont Hospital, Montreal (Canada)

12 More presentations in this session

Presentation thumbnail
Safety and effectiveness of endovasal lead extraction in patients with bacterial endocarditis: the olomouc lead extraction study.
Professor M. Taborsky (Usti Nad Labem, CZ)
Abstract Slides
Presentation thumbnail
WCD-Utilisation in heart-failure-patients with reduced EF (<35%) during waiting time for SCD-risk assessment -Recovery depending on age and baseline ejection fraction-
Mr L. Lichtenberg (Cologne, DE)
Abstract
Presentation thumbnail
Icd use in arrhythmogenic right ventricular cardiomyopathy: prophylactic v secondary indication
Doctor M. Gardner (Halifax, CA)
Abstract Slides
Presentation thumbnail
Meta-analysis of long-term outcomes of implantation of internal cardioverter defibrillators in patients with inherited cardiac channelopathies
Doctor F. Del Carpio (Rochester, US)
Abstract
Presentation thumbnail
Safety and efficacy of leadless pacemaker implant: a single centre experience.
Doctor F. Chipa Ccasani (Esplugues de Llobregat, ES)
Abstract

Access the full session

Session thumbnail
Poster session 2 - ICD

The Event

Event poster

ESC Congress 2017

26 August - 30 August 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources